---
title: "CLENE INC C/WTS 30/12/2025 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 15 K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265731670.md"
datetime: "2025-11-13T12:54:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265731670.md)
  - [en](https://longbridge.com/en/news/265731670.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265731670.md)
generator: "portal-rs"
---

# CLENE INC C/WTS 30/12/2025 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 15 K

Revenue: As of FY2025 Q3, the actual value is USD 15 K.

EPS: As of FY2025 Q3, the actual value is USD -0.85.

EBIT: As of FY2025 Q3, the actual value is USD -5.039 M.

### Segment Revenue

-   **Total Revenue**: $15,000 for the three months ended September 30, 2025, compared to $87,000 for the same period in 2024, representing an 83% decrease. For the nine months ended September 30, 2025, total revenue was $123,000, compared to $251,000 for the same period in 2024, a 51% decrease.

### Operational Metrics

-   **Loss from Operations**: - $5,648,000 for the three months ended September 30, 2025, compared to - $7,815,000 for the same period in 2024, a 28% decrease. For the nine months ended September 30, 2025, the loss from operations was - $15,588,000, compared to - $24,438,000 for the same period in 2024, a 36% decrease.
-   **Net Loss**: - $8,777,000 for the three months ended September 30, 2025, compared to - $7,986,000 for the same period in 2024, a 10% increase. For the nine months ended September 30, 2025, the net loss was - $16,947,000, compared to - $25,851,000 for the same period in 2024, a 34% decrease.

### Cash Flow

-   **Net Cash Used in Operating Activities**: - $13,747,000 for the nine months ended September 30, 2025, compared to - $16,461,000 for the same period in 2024.
-   **Net Cash Provided by Financing Activities**: $9,448,000 for the nine months ended September 30, 2025, compared to - $4,057,000 used in the same period in 2024.

### Unique Metrics

-   **Research and Development Expense**: $3,513,000 for the three months ended September 30, 2025, compared to $4,471,000 for the same period in 2024, a 21% decrease. For the nine months ended September 30, 2025, research and development expenses were $8,508,000, compared to $14,490,000 for the same period in 2024, a 41% decrease.
-   **General and Administrative Expense**: $2,150,000 for the three months ended September 30, 2025, compared to $3,413,000 for the same period in 2024, a 37% decrease. For the nine months ended September 30, 2025, general and administrative expenses were $7,183,000, compared to $10,147,000 for the same period in 2024, a 29% decrease.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to submit a New Drug Application (NDA) for CNM-Au8 under an accelerated approval pathway in the first quarter of 2026, contingent on positive data from ongoing studies. They also plan to commence a confirmatory Phase 3 trial, RESTORE-ALS, in the first half of 2026, contingent on funding.
-   **Non-Core Business**: The company is exploring additional funding options, including equity financing, debt financing, and collaboration arrangements, to support its operations and strategic initiatives.

### Related Stocks

- [CLNNW.US](https://longbridge.com/en/quote/CLNNW.US.md)

## Related News & Research

- [Zscaler (ZS) Is Down 5.1% After Issuing 2027 Guidance And Filing US$1.69 Billion Shelf Registration – Has The Bull Case Changed?](https://longbridge.com/en/news/298038986.md)
- [Michael Burry Called This Stock the 'Trickster' in His Portfolio: Says It's 'Determined' to Take Him Where 'Mermaids Fear to Tread'](https://longbridge.com/en/news/297990287.md)
- [McDonald's Stock (MCD) Hits 52-Week Low. Here's What's Holding Back the Burger Chain](https://longbridge.com/en/news/298057026.md)
- [Lululemon's Comparable Sales Fell 9%. Can New CEO Heidi O'Neill Turn Things Around or Is the Brand Broken?](https://longbridge.com/en/news/298017136.md)
- [Premier Path Wealth Partners LLC Acquires 7,360 Shares of KLA Corporation $KLAC](https://longbridge.com/en/news/298020303.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**